Sandra Navarra

9.2k citations
81 papers · 4.2k · 4 hit papers · h-index 24

Impact in

  • Rheumatology top 0.1%
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
  • Immunology top 1%
    • T-cell and B-cell Immunology
    • Atherosclerosis and Cardiovascular Diseases
    • Immune Cell Function and Interaction

Papers in

    • Systemic Lupus Erythematosus Research 55
    • Rheumatoid Arthritis Research and Therapies 7
    • Spondyloarthritis Studies and Treatments 6
    • Systemic Sclerosis and Related Diseases 5

Sandra Navarra

72 papers receiving 4.1k citations

Sandra Navarra's Hit Papers

Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study 2018 · 228 citations
2280+5+10Years since publication4008001.2k

Peers

Sandra Navarra
Comparison fields: 5 of 99
  • Rheumatology 3.1k
  • Immunology 1.5k
  • Nephrology 327
  • Radiology, Nuclear Medicine and Imaging 830
  • Hepatology 147
Replace Joung-Liang Lan with:
Joung-Liang Lan Taiwan
Anca Askanase United States
Graham Hughes United Kingdom
Mathew Thomas United States
Maria Greenwald United States
Hideto Kameda Japan
Xinping Tian China
John Tesser United States
Hanno B. Richards United States
J. R. Kalden Germany
Sandra Navarra relative to Joung-Liang Lan Taiwan Joung-Liang Lan's profile →
Citations per field
00.5×3.1×
Joung-Liang Lan · 1×
Citations per year

Countries citing papers authored by Sandra Navarra

Since Specialization
Citations

This map shows the geographic impact of Sandra Navarra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Navarra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Navarra more than expected).

Fields of papers citing papers by Sandra Navarra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Navarra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Navarra. The network helps show where Sandra Navarra may publish in the future.

Co-authors

The 25 scholars most cited alongside Sandra Navarra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandra Navarra Line = papers co-authored together Sandra Navarra links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Hit paper breakdown →
20111426
2
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
Hit paper breakdown →
2015466
3
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials
Hit paper breakdown →
2012292
4 2011255
5
Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study
Hit paper breakdown →
2018228
6 2013140
7 2004132
8 202284
9 202280
10 200877
11 201875
12 201964
13 201359
14 202358
15 201251
16 201351
17 202150
18 201743
19 201342
20 201734

About Sandra Navarra

Sandra Navarra is a scholar working on Rheumatology, Pathology and Forensic Medicine, Immunology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 81 papers that have together received 4.2k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (55 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Rheumatoid Arthritis Research and Therapies (7 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Spondyloarthritis Studies and Treatments (6 papers), Liver Diseases and Immunity (5 papers), Systemic Sclerosis and Related Diseases (5 papers) and Gout, Hyperuricemia, Uric Acid (4 papers). The work is most often cited by research in Rheumatology (3.1k citations), Immunology (1.5k citations), Nephrology (327 citations), Radiology, Nuclear Medicine and Imaging (830 citations) and Hepatology (147 citations). Sandra Navarra has collaborated with scholars based in Philippines, United States and United Kingdom. Frequent co-authors include Michelle Petri, Z. John Zhong, William W. Freimuth, Roger A. Levy, Mathew Thomas, Stephen Hall, C Tănăsescu, A Gallacher, Е. Л. Насонов and Ho‐Youn Kim. Their work appears in journals such as Annals of the Rheumatic Diseases, Modern Rheumatology, RMD Open, Arthritis Care & Research and The Lancet Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact